Skip to main content
. 2014 Jul 30;15:258. doi: 10.1186/1471-2474-15-258

Table 3.

Stratification of 128 respondents according to confidence and non-confidence in knowledge regarding cannabinoid molecules

 
Not confident
Confident
P value
  n = 95 N = 33  
Is there a role for use of any of the following options for rheumatic conditions? n (%)
 
 
 
 Pharma only
21 (22)
10 (30)
NS
 Medical cannabis
22 (23)
16 (48)
.008
 No role
50 (53)
7 (21)
.0006
 Did not answer
2 (2)
0 (0)
 
Have you previously recommended a trial of the following? n (%)
 
 
 
 Pharma only
11 (12)
11 (33)
.007
 Medical cannabis
7 (7)
9 (27)
.006
 Never
77 (81)
13 (39)
< .0001
Would you recommend a trial of the following? n (%)
 
 
 
 Pharma only
15 (16)
10 (30)
NS
 Medical cannabis
13 (14)
12 (36)
.009
 None
65 (68)
11 (33)
.0008
 Did not answer
2 (2)
0 (0)
 
Would you write a medical cannabis prescription for a patient failing conventional treatments? n (%)
 
 
 
 Yes
22 (23)
14 (42)
.043
 No
70 (74)
17 (52)
.029
 Did not answer
3 (3)
2 (6)
 
Would you write a medical cannabis prescription based on patient request regardless of previous treatments? n (%)
 
 
 
 Yes
2 (2)
3 (9)
NS
 No
90 (95)
28 (85)
NS
Did not answer
3 (3)
2 (6)
 
Confidence level regarding writing a medical cannabis prescription (dose, frequency) n (%)
 
 
 
 Expressed confidence
3 (3)
9 (27)
.0002
 Not confident
92 (97)
23 (70)
< .0001
 Did not answer 0 (0) 1 (3)